Key facts
- This page summarizes Andrew J. Last's Form 4 filing for BIO-RAD LABORATORIES, INC. (BIO).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 10 Sep 2024, 14:05.
Andrew J. Last - 06 Sep 2024 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)
- Reporting relationship
- EVP, Chief Operating Officer
- Issuer ticker
- BIO
- Reported as of
- 06 Sep 2024
- Net transaction value
- -$92,095
- SEC form
- 4
- Accepted by SEC
- 10 Sep 2024, 14:05:38 UTC
- Prior SEC filing
- 04 Sep 2024
- Next SEC filing
- 03 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrew J. Last
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Andrew J. Last filed Form 4 for BIO-RAD LABORATORIES, INC. (BIO) on 10 Sep 2024.
Change
- Previous filing in this sequence was filed on 04 Sep 2024.
- Current net transaction value: -$92,095.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIO BIOB
transaction
Bio-Rad A Common Stock
Options Exercise
- Transaction value
- $897,720
- Shares
- +3,000
- Change %
- +40%
- Price
- $299.24
- Shares after
- 10,559
- Date
- 06 Sep 2024
- Ownership
- Direct
BIO BIOB
transaction
Bio-Rad A Common Stock
Sale
- Transaction value
- $989,815
- Shares
- -3,000
- Change %
- -28%
- Price
- $329.94
- Shares after
- 7,559
- Date
- 06 Sep 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIO BIOB
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -3,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 06 Sep 2024
- Ownership
- Direct
- Underlying class
- Bio-Rad A Common Stock
- Underlying amount
- 3,000
- Exercise price
- $299.24
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The option, representing a right to purchase a total of 5,000 shares, became exercisable in five equal annual installments beginning on April 29, 2019, which was the first anniversary of the date on which the option was granted.